Involvement of 5-hydroxytryptamine1A receptors in Δ9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice

European Journal of Pharmacology

Volumn 550, Issue 1-3, 2006, Pages 117-122

  Egashira, Nobuaki ^a   Matsuda, Tomomi ^a   Koushi, Emi ^a   Mishima, Kenichi ^a   Iwasaki, Katsunori ^a   Shoyama, Yukihiro ^b   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

9 tetrahydrocannabinol; (Mouse); 5 HT (5 hydroxytryptamine, serotonin); 5 HT1A receptor; Cannabinoids; Catalepsy

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; BUSPIRONE; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RIMONABANT; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; PHENOL DERIVATIVE; PIPERAZINE DERIVATIVE; PSYCHEDELIC AGENT; PYRIDINE DERIVATIVE; SULFONAMIDE; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; IMMOBILIZATION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; ROTAROD TEST; ANIMAL; BODY EQUILIBRIUM; CHEMICALLY INDUCED DISORDER; MOTOR ACTIVITY; PATHOPHYSIOLOGY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BUSPIRONE; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MALE; MICE; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; PHENOLS; PIPERAZINES; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SULFONAMIDES; TETRAHYDROCANNABINOL;

EID: 33750012661     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.051     Document Type: Article

References (41)

1. Anderson J.J., Kask A.M., and Chase T.N. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. Eur. J. Pharmacol. 295 (1996) 163-168
2. 1A agonist properties. Neuropsychopharmacology 31 (2006) 1869-1879
3. Barnes N.M., and Sharp T.A. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
4. 1A receptors are not involved in clozapine's lack of cataleptogenic potential. Neuropharmacology 35 (1996) 1645-1646
5. 1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. Eur. Neuropsychopharmacol. 14 (2004) 487-495
6. 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res. 952 (2002) 239-245
7. 9-tetrahydrocannabinol-induced impairment of spatial memory. Eur. J. Pharmacol. 445 (2002) 221-229
8. Egashira N., Tanoue A., Higashihara F., Mishima K., Fukue Y., Takano Y., Tsujimoto G., Iwasaki K., and Fujiwara M. V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci. Lett. 356 (2004) 195-198
9. Egashira N., Tanoue A., Higashihara F., Fuchigami H., Sano K., Mishima K., Fukue Y., Nagai H., Takano Y., Tsujimoto G., Stemmelin J., Griebel G., Iwasaki K., Ikeda T., Nishimura R., and Fujiwara M. Disruption of the prepulse inhibition of the startle reflex in vasopressin V1b receptor knockout mice: reversal by antipsychotic drugs. Neuropsychopharmacology 30 (2005) 1996-2005
10. 9-tetrahydrocannabinol by clomipramine in the rat. Br. J. Pharmacol. 63 (1978) 267-273
11. 1A receptor antagonist. Behav. Brain Res. 73 (1996) 337-353
12. 1A receptor antagonist, WAY-100635. Eur. J. Pharmacol. 281 (1995) 81-88
13. 1 cannabinoid receptor and development of therapeutic application. J. Pharmacol. Sci. 96 (2004) 362-366
14. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
15. 1A receptor agonist 8-OH-DPAT on the release of 5-HT in dorsal and median raphe-innervated rat brain regions as measured by in vivo microdialysis. Life Sci. 48 (1991) 1779-1786
16. Hoffman A.F., and Lupica C.R. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids. J. Neurophysiol. 85 (2001) 72-83
17. 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats. Neurotox. Res. 6 (2004) 153-158
18. 1A receptor antagonist, NAD-299. J. Pharmacol. Exp. Ther. 283 (1997) 216-225
19. 1A receptor ligands in a modified Geller-Seifter conflict model in the rat. Eur. J. Pharmacol. 325 (1997) 121-128
20. 9-tetrahydrocannabinol in mice. J. Neural. Transm.: Gen. Sect. 95 (1994) 137-143
21. 1A receptor activation in attenuation of catalepsy induction in rats. Neuropharmacology 49 (2005) 135-143
22. Lichtman A.H., and Martin B.R. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacol. Biochem. Behav. 57 (1997) 7-12
23. 1A receptors. Br. J. Pharmacol. 108 (1993) 669-677
24. 9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat. Br. J. Pharmacol. 124 (1998) 1419-1424
25. 9-tetrahydrocannabinol-induced hypothermia in the rat. Pharmacol. Biochem. Behav. 69 (2001) 595-601
26. Manzoni O.J., and Bockaert J. Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens. Eur. J. Pharmacol. 412 (2001) R3-R5
27. 9-THC-treated rats: possible clinical implications. Br. J. Pharmacol. 140 (2003) 520-526
28. Neal-Beliveau B.S., Joyce J.N., and Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. J. Pharmacol. Exp. Ther. 265 (1993) 207-217
29. 1 receptor gene expression in mice. Behav. Brain Res. 72 (1995) 115-125
30. Pazos A., and Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I serotonin-1 receptors. Brain Res. 346 (1985) 205-230
31. 9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 27 (1988) 1265-1270
32. Pires J.G., Bonikovski V., and Futuro-Neto H.A. Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice. Braz. J. Med. Biol. Res. 38 (2005) 1867-1872
33. 1A ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects. Psychopharmacology 144 (1999) 20-29
34. 1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy. Eur. J. Pharmacol. 453 (2002) 217-221
35. Robbe D., Alonso G., Duchamp F., Bockaert J., and Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21 (2001) 109-116
36. 1 receptor mediation of cannabinoid behavioral effects in male and female rats. Psychopharmacology 172 (2004) 25-30
37. 1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
38. 9-tetrahydrocannabinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J. Pharmacol. Exp. Ther. 314 (2005) 329-337
39. 1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 6 (1986) 3474-3482
40. 2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Pharmacol. Biochem. Behav. 47 (1994) 509-513
41. Yan Q.S., Reith M.E., Jobe P.C., and Dailey J.W. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 765 (1997) 149-158